Forum Financial Management LP Buys 35 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Forum Financial Management LP raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,966 shares of the medical equipment provider’s stock after purchasing an additional 35 shares during the quarter. Forum Financial Management LP’s holdings in Intuitive Surgical were worth $966,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Ullmann Wealth Partners Group LLC boosted its position in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares in the last quarter. One Wealth Management Investment & Advisory Services LLC boosted its position in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares in the last quarter. Daymark Wealth Partners LLC boosted its position in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after buying an additional 24 shares in the last quarter. Indiana Trust & Investment Management CO boosted its position in Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares in the last quarter. Finally, Hoxton Planning & Management LLC boosted its position in Intuitive Surgical by 4.9% in the second quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after buying an additional 25 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 68,246 shares of company stock worth $33,839,308. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on ISRG shares. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Barclays upped their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Morgan Stanley upped their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research report on Monday, July 15th. Finally, Mizuho upped their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $507.42 on Tuesday. The firm has a 50-day moving average of $490.97 and a 200-day moving average of $448.54. The stock has a market cap of $180.73 billion, a PE ratio of 81.58, a P/E/G ratio of 4.95 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $269.49 and a 52-week high of $523.34.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.